Regeneron Pharmaceuticals ( NASDAQ: REGN) said on Thursday that the U.S. FDA will be reviewing the supplemental biologics license application ( (sBLA)) for Eylea HD injection, 8 mg, to treat macular ...

Brainstorm Cell Therapeutics is seeking FDA clearances to launch a Phase 3b clinical trial to test its NurOwn stem cell therapy for ALS.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Fans are speculating whether Oprah Winfrey is showing signs of a surprising new weight-loss drug side effect known as ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

The Trump administration plans to slash annual discretionary spending at the US federal health department by around one-third ...

Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy ...

U.S. President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad ...

Scilex (SCLX) announced that FDA has approved the company’s request for the orphan drug designation for colchicine for the treatment of ...

Medline Unite announced today that it received FDA 510(k) clearance for its Reflex Hybrid nitinol implant system.

OpenAI has named labor leader Dolores Huerta and three others to an advisory board that will help guide the artificial intelligence company’s philanthropy as it attempts to shift itself into ...